Bicara Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	436.61	489.71	230.44	4.16
Cash & Short-Term Investments	436.61	489.71	230.44	4.16
Cash Growth	114.18%	112.51%	5442.09%	-
Receivables	-	-	0.1	0.07
Prepaid Expenses	7.79	12.82	0.53	0.76
Total Current Assets	444.39	502.53	231.07	4.98
Property, Plant & Equipment	2.35	0.85	0.82	0.64
Other Long-Term Assets	6.84	6.62	1.99	0.94
Total Assets	453.59	510	233.98	6.7
Accounts Payable	2.91	4.51	3.19	5.14
Accrued Expenses	13.24	12.88	11.61	18.76
Current Portion of Leases	1.07	0.61	0.29	-
Total Current Liabilities	17.23	17.99	15.09	23.9
Long-Term Leases	1.16	0.13	0.37	-
Other Long-Term Liabilities	-	-	0.02	0.09
Total Liabilities	18.39	18.12	15.47	23.98
Common Stock	0.01	0.01	0	0
Additional Paid-In Capital	720.44	712.88	4.25	2.23
Retained Earnings	-285.25	-221.02	-153.02	-101.04
Total Common Equity	435.2	491.88	-148.77	-98.8
Shareholders' Equity	435.2	491.88	218.51	-17.28
Total Liabilities & Equity	453.59	510	233.98	6.7
Total Debt	2.24	0.74	0.66	-
Net Cash (Debt)	434.37	488.97	229.78	4.16
Net Cash Growth	113.62%	112.80%	5426.29%	-
Net Cash Per Share	9.95	29.10	396.10	9.69
Filing Date Shares Outstanding	54.56	54.52	34.26	0.43
Total Common Shares Outstanding	54.56	54.44	0.64	0.43
Working Capital	427.16	484.54	215.99	-18.91
Book Value Per Share	7.98	9.04	-232.15	-230.26
Tangible Book Value	435.2	491.88	-148.77	-98.8
Tangible Book Value Per Share	7.98	9.04	-232.15	-230.26

Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q